HOMEwww.epgonline.orgDRUGSwww.epgonline.orgDISEASE KNOWLEDGEwww.epgonline.orgGUIDELINESwww.epgonline.orgCLINICAL TRIALSwww.epgonline.orgNEWSwww.epgonline.orgREGISTER
Members
Why a doctor should
Username/Email

Password ()




EPG on Twitter EPG Online Twitter
EPG Online Blog EPG Online Blog
EPG Online Disease Knowledge Centres Feed Disease Knowledge
Recent UK Drug Updates Drug Updates
EPG Search
Search
Languages

No approved articles at present.


View all articles
Submit an article
Thrombosis risk may be raised by cancer drugs
Cancer patients receiving drugs to lower the risk of anaemia may be...
Published Tuesday 01 December 2009

Chemotherapy can result in insomnia
Insomnia occurs in approximately three-quarters of cancer patients who have undergone chemotherapy....
Published Tuesday 01 December 2009

Osteoarthritis risk increased by high exercise levels
Men and women in middle age who exercise on a regular basis...
Published Monday 30 November 2009

Cancer genome changes increase cervical cancer relapse risk
Patients with cervical cancer are three to four times more likely to...
Published Sunday 29 November 2009

Number of Americans with diabetes expected to double by 2034
The number of people developing diabetes in the US is expected to...
Published Sunday 29 November 2009

H1N1 virus appears to increase asthma risk in children
Asthma is a significant risk factor in children who have contracted the...
Published Sunday 29 November 2009

New treatment could prevent thrombosis in PAD patients
Thrombosis is a common side effect in patients undergoing bypass surgery for...
Published Sunday 29 November 2009

More Medical News
Hepatitis Cystic Fibrosis Advancing Immunotherapy in Oncology Alzheimer's disease (AD) is a progressive, neurodegenerative disease which will affect most of us at one point in time, and it’s prevalence increases with age.

Niemann-Pick Type C

Please note- The EPG Niemann-Pick Type C Knowledge Centre is for Doctors and other Healthcare Professionals.

Niemann-Pick Type C Knowledge Centre

Niemann-Pick type C disease is a rare genetic lysosomal storage disorder that causes severe, progressive neurological symptoms. It is a very serious, life-threatening condition that can affect infants, children and adults. NP-C is characterized by cellular accumulation of lipids, in particular unesterified cholesterol and glycosphingolipids, in many parts of the body including brain, liver and spleen.

The variability of NPC presentations provides a wide range of life expectancy. In general, early-onset patients tend to die during childhood or early adolescence, while patients with later-onset disease who appear to be less drastically affected can live into late adulthood.

Accurate diagnosis of NPC requires awareness of many clinical phenotypes, narrowing of differential diagnosis by ancillary testing and final confirmation by biochemical testing – the current mainstay of primary diagnosis in NPC.

The prevalence of NPC has undoubtedly been underestimated in the past due to a mixture of factors including confusing terminology, prior lack of specific biochemical or genetic tests, varied pathology, and the many variant clinical manifestations of the disease.

Current, non-specific treatments for NPC focus mainly on supportive care, aimed toward managing the symptoms of the disease. As such, these treatments have no effect on disease progression or long-term outcomes.

Specific therapies for the intended treatment of NPC are based on targeting known pathophysiological and/or biochemical defects involved in the pathogenesis of the disease. While earlier attempts proved largely ineffective, more recent efforts indicate possible hope for the future. 

Enter the Niemann-Pick Type C Knowledge Centre

What’s in the Niemann-Pick Type C Knowledge Centre?

Cholesterol

Cholesterol

DRUG UPDATES Drug updates feed

HEALTH JOBS

Latest healthcare vacancies for a variety of medical specialties

Visit The Latest EPG Health Jobs

CONNECT

DISEASE CENTRES Disease Centres feed

QUICK SEARCH

GUIDELINES UK Drug Data Feed

DRUG DATA UK Drug Data Feed

REFFERENCES